Your browser doesn't support javascript.
loading
Proton therapy induces a local microglial neuroimmune response.
Voshart, Daniëlle C; Klaver, Myrthe; Jiang, Yuting; van Weering, Hilmar R J; van Buuren-Broek, Fleur; van der Linden, Gideon P; Cinat, Davide; Kiewiet, Harry H; Malimban, Justin; Vazquez-Matias, Daniel A; Reali Nazario, Luiza; Scholma, Ayla C; Sewdihal, Jeffrey; van Goethem, Marc-Jan; van Luijk, Peter; Coppes, Rob P; Barazzuol, Lara.
Afiliación
  • Voshart DC; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • Klaver M; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • Jiang Y; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • van Weering HRJ; Department of Biomedical Sciences, Section of Molecular Neurobiology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • van Buuren-Broek F; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • van der Linden GP; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • Cinat D; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • Kiewiet HH; Department of Biomedical Sciences, PARTREC, University Medical Center Groningen, University of Groningen, Groningen 9747 AA, The Netherlands.
  • Malimban J; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands.
  • Vazquez-Matias DA; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • Reali Nazario L; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • Scholma AC; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • Sewdihal J; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • van Goethem MJ; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, PARTREC, University Medical Center Groningen, University of Groningen, Groningen 9747 AA, The Netherlands.
  • van Luijk P; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • Coppes RP; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
  • Barazzuol L; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands; Department of Biomedical Sciences, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Groningen 9700 AD, The Netherlands.
Radiother Oncol ; 193: 110117, 2024 04.
Article en En | MEDLINE | ID: mdl-38453539
ABSTRACT
BACKGROUND AND

PURPOSE:

Although proton therapy is increasingly being used in the treatment of paediatric and adult brain tumours, there are still uncertainties surrounding the biological effect of protons on the normal brain. Microglia, the brain-resident macrophages, have been shown to play a role in the development of radiation-induced neurotoxicity. However, their molecular and hence functional response to proton irradiation remains unknown. This study investigates the effect of protons on microglia by comparing the effect of photons and protons as well as the influence of age and different irradiated volumes. MATERIALS AND

METHODS:

Rats were irradiated with 14 Gy to the whole brain with photons (X-rays), plateau protons, spread-out Bragg peak (SOBP) protons or to 50 % anterior, or 50 % posterior brain sub-volumes with plateau protons. RNA sequencing, validation of microglial priming gene expression using qPCR and high-content imaging analysis of microglial morphology were performed in the cortex at 12 weeks post irradiation.

RESULTS:

Photons and plateau protons induced a shared transcriptomic response associated with neuroinflammation. This response was associated with a similar microglial priming gene expression signature and distribution of microglial morphologies. Expression of the priming gene signature was less pronounced in juvenile rats compared to adults and slightly increased in rats irradiated with SOBP protons. High-precision partial brain irradiation with protons induced a local microglial priming response and morphological changes.

CONCLUSION:

Overall, our data indicate that the brain responds in a similar manner to photons and plateau protons with a shared local upregulation of microglial priming-associated genes, potentially enhancing the immune response to subsequent inflammatory challenges.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia de Protones Límite: Animals / Child / Humans Idioma: En Revista: Radiother Oncol Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia de Protones Límite: Animals / Child / Humans Idioma: En Revista: Radiother Oncol Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos